Toronto Stock Exchange · Healthcare
Invest in Vitalhub stock from India
Indian and foreign residents can buy Vitalhub (VHI) shares directly through Paasa.
By Paasa · Updated
Vitalhub at a glance
- Price
- CA$7.54+CA$0.21 (2.86%)
- Market cap
- CA$476.98M
- Day range
- CA$7.31 – CA$7.54
- P/E
- 63.58
- Dividend yield
- None
- Volume
- 69.10K
- 1 month
- -12.43%
- 6 months
- +8.49%
- YTD
- -20.38%
- 1 year
- -32.56%
- 5 years
- +160.90%
Vitalhub statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CA$109.0M | CA$68.6M | CA$52.5M | CA$40.0M | CA$24.7M |
| Gross profit | CA$76.5M | CA$55.5M | CA$42.8M | CA$32.9M | CA$19.4M |
| Operating income | CA$12.2M | CA$9.7M | CA$6.9M | CA$4.7M | CA$324.3K |
| Net income | CA$6.1M | CA$3.0M | CA$4.5M | CA$1.2M | −CA$1.9M |
| Earnings per share | CA$0.10 | CA$0.06 | CA$0.10 | CA$0.03 | −CA$0.05 |
| EBITDA | CA$17.1M | CA$11.9M | CA$10.4M | CA$5.3M | CA$1.1M |
| Total assets | CA$352.7M | CA$207.2M | CA$118.8M | CA$106.2M | CA$72.8M |
| Total debt | CA$2.5M | CA$608.8K | CA$541.1K | CA$882.2K | CA$792.5K |
| Cash and short-term investments | CA$119.2M | CA$56.6M | CA$33.5M | CA$17.5M | CA$16.4M |
| Shareholders' equity | CA$265.9M | CA$144.9M | CA$81.9M | CA$75.4M | CA$54.8M |
| Operating cash flow | CA$8.3M | CA$15.1M | CA$20.5M | CA$6.1M | −CA$50.0K |
| Free cash flow | CA$7.9M | CA$14.2M | CA$20.2M | CA$5.8M | −CA$309.6K |
| Capital expenditure | −CA$423.1K | −CA$883.7K | −CA$290.1K | −CA$295.0K | −CA$259.6K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CAD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Knight Therapeutics | GUD.TO | CA$10.35 | CA$1.02B |
| Bright Minds Biosciences | DRUG.CN | $71.27 | $697.53M |
| Verano | VRNO.NE | CA$8.52 | CA$629.78M |
| Kneat | KSI.TO | CA$6.50 | CA$624.86M |
| Cresco Labs | CL.CN | $1.03 | $364.85M |
| Aurora Cannabis | ACB.TO | CA$5.71 | CA$353.69M |
| High Tide | HITI.V | CA$3.98 | CA$349.72M |
| Cipher Pharmaceuticals | CPH.TO | CA$13.69 | CA$347.61M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Vitalhub from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CAD when you buy.
Step 3
Search VHI and buy
Find Vitalhub by name or by its ticker, VHI, and place your order.
Why invest in Vitalhub from India
What Vitalhub does
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Vitalhub operates in the Medical - Healthcare Information Services industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Vitalhub stock from India?
Yes. Indian residents and NRIs can buy Vitalhub (VHI) shares directly through Paasa. Vitalhub is listed on the Toronto Stock Exchange, in the Medical - Healthcare Information Services industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Vitalhub shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CAD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.